ATE349216T1 - Behandlung von darmverstopfung - Google Patents

Behandlung von darmverstopfung

Info

Publication number
ATE349216T1
ATE349216T1 AT98918987T AT98918987T ATE349216T1 AT E349216 T1 ATE349216 T1 AT E349216T1 AT 98918987 T AT98918987 T AT 98918987T AT 98918987 T AT98918987 T AT 98918987T AT E349216 T1 ATE349216 T1 AT E349216T1
Authority
AT
Austria
Prior art keywords
intestinal
constitution
treatment
intestinal constitution
Prior art date
Application number
AT98918987T
Other languages
English (en)
Inventor
Thomas Julius Borody
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Borody Thomas J filed Critical Borody Thomas J
Application granted granted Critical
Publication of ATE349216T1 publication Critical patent/ATE349216T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98918987T 1997-05-07 1998-05-07 Behandlung von darmverstopfung ATE349216T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO6653A AUPO665397A0 (en) 1997-05-07 1997-05-07 Novel therapy for constipation

Publications (1)

Publication Number Publication Date
ATE349216T1 true ATE349216T1 (de) 2007-01-15

Family

ID=3800945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98918987T ATE349216T1 (de) 1997-05-07 1998-05-07 Behandlung von darmverstopfung

Country Status (13)

Country Link
US (1) US6426338B1 (de)
EP (1) EP0980246B1 (de)
AR (1) AR012671A1 (de)
AT (1) ATE349216T1 (de)
AU (1) AUPO665397A0 (de)
CA (1) CA2289717C (de)
CY (1) CY1107586T1 (de)
DE (1) DE69836735T2 (de)
DK (1) DK0980246T3 (de)
ES (1) ES2279573T3 (de)
PT (1) PT980246E (de)
WO (1) WO1998050043A1 (de)
ZA (1) ZA983852B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1642885B1 (de) * 2000-08-29 2009-11-11 Biocon Limited Verwendung einer pharmazeutischen Zusammensetzung mit einem Para-Aminophenylessigsäurederivat für die Behandlung von entzündlichen Erkrankungen des Magen-Darmtrakts
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
DE10257824B4 (de) * 2002-12-10 2004-11-11 Kochem, Hans-Günter, Dr. Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen
US20050075395A1 (en) * 2003-05-28 2005-04-07 Gary Gordon Continuous dosing regimen
EP1644008B1 (de) * 2003-05-29 2011-12-21 Abbott Laboratories Kontinuierliches dosierschema mit abt-751
US20040242649A1 (en) * 2003-05-29 2004-12-02 Hagey Anne E. Extended dosing regimen
HUE029189T2 (en) * 2004-02-06 2017-02-28 Pharmatel (R&D) Pty Ltd As Trustee For The Pharmatel (R & D) Trust The use of aminosalicylates in diarrhea prodominant irritable bowel syndrome
US20050191371A1 (en) * 2004-02-12 2005-09-01 Rizo Andres M. Medical composition
KR20130028807A (ko) * 2004-05-28 2013-03-19 샐릭스 파마슈티컬스 인코포레이티드 방사선 유발성 장염의 예방, 치료 및 개선 방법
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN102670626A (zh) * 2005-08-24 2012-09-19 萨利克斯药品公司 巴柳氮制剂及其生产和应用
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
AU2010312309B2 (en) 2009-10-26 2016-10-06 Thomas Julius Borody Novel enteric combination therapy
WO2011094027A1 (en) 2010-02-01 2011-08-04 Hlavka Edwin J Bacteriotherapy for clostridium difficile colitis
BR112012027520A2 (pt) 2010-04-26 2015-09-15 Salix Pharmaceuticals Ltd formulações e usos de derivados de ácido 2-hidroxi-5-fenilazobenzoico para o tratamento de indivíduos do sexo masculino
SG191145A1 (en) 2010-12-13 2013-07-31 Borody Thomas J Gastric and colonic formulations and methods for making and using them
US20150164831A1 (en) * 2012-03-30 2015-06-18 Takeda Pharmaceuticals U.S.A., Inc. Colchicine formulations; methods of making; and methods of use thereof
WO2014016671A2 (en) 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
EP4234011A3 (de) 2013-06-05 2023-09-20 Rebiotix, Inc. Mikrobiotawiederherstellungstherapie (mrt), zusammensetzungen und verfahren zur herstellung
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
CN107921072A (zh) 2015-06-09 2018-04-17 雷柏奥提斯有限公司 微生物群恢复治疗（mrt）组合物和制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3425441B2 (ja) * 1990-10-22 2003-07-14 ガストロ サービシイズ ピーティーワイ リミテッド 非炎症性及び非感染性腸障害の処置
US5519014A (en) * 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders

Also Published As

Publication number Publication date
DE69836735T2 (de) 2007-10-11
EP0980246B1 (de) 2006-12-27
EP0980246A4 (de) 2004-04-14
US6426338B1 (en) 2002-07-30
ES2279573T3 (es) 2007-08-16
ZA983852B (en) 1998-11-13
CA2289717C (en) 2009-02-03
PT980246E (pt) 2007-02-28
AUPO665397A0 (en) 1997-05-29
CY1107586T1 (el) 2013-03-13
EP0980246A1 (de) 2000-02-23
WO1998050043A1 (en) 1998-11-12
DK0980246T3 (da) 2007-05-07
DE69836735D1 (de) 2007-02-08
AR012671A1 (es) 2000-11-08
CA2289717A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
DE69817446D1 (de) Behandlung von diabetes
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69835011D1 (de) Unterschiedliche behandlung von prothesenteilen
ATE301617T1 (de) Behandlung von wasser
DE69500089D1 (de) Behandlung von Geflügel
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
ATE260332T1 (de) Behandlung von textilien
DE69836735D1 (de) Behandlung von darmverstopfung
DE69926385D1 (de) Behandlung von geweben
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69840969D1 (de) Vorbeugung und Behandlung von amyloidogener Krankheit
ATE235236T1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
EP0996433A4 (de) Behandlungsverfahren von lactosylceramidbedingten zuständen
DE69530486D1 (de) Behandlung von uteriner fibrosis
DE69810499D1 (de) Behandlung von industriegeweben
EP1117431A4 (de) Behandlung von acidose
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
EP1239851A4 (de) Behandlung von hyperproliferativen erkrankungen
DE69932235D1 (de) Behandlung von herzhypertrophie
DE69926485D1 (de) Behandlung von durchblasgasen
DE69522685D1 (de) Behandlung von blut-plasma
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69802300D1 (de) Behandlung von schädlichen flüssigkeiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0980246

Country of ref document: EP